Rezolute, Inc. (RZLT): Depreciation & Amortization
$31.0K
Year ended 2026-06-30
+1.1%
3-year compound annual growth
+19.0%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $31.0K | 0.0% | 2026-09-24, From 2025-07-01 |
| 2025-06-30 | $31.0K | -13.9% | 2026-09-24, From 2024-07-01 |
| 2024-06-30 | $36.0K | +20.0% | 2025-09-17, From 2023-07-01 |
| 2023-06-30 | $30.0K | +130.8% | 2024-09-19, From 2022-07-01 |
| 2022-06-30 | $13.0K | 0.0% | 2023-09-14, From 2021-07-01 |
| 2021-06-30 | $13.0K | -27.8% | 2022-09-15, From 2020-07-01 |
| 2020-06-30 | $18.0K | -63.3% | 2021-09-15, From 2019-07-01 |
| 2019-06-30 | $49.0K | -95.4% | 2020-10-13, From 2018-07-01 |
| 2018-06-30 | $1.07M | n/a | 2019-09-10, From 2017-07-01 |
| No annual figure between 2014-06-30 and 2018-06-30. | |||
| 2014-06-30 | $11.3K | n/m | 2014-09-30, From 2013-07-01 |
| 2013-06-30 | $295 | n/a | 2014-09-30, From 2012-07-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Rezolute, Inc. (RZLT) | 2026-06-30 | $31.0K | 0.0% |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $114.0K | +8.6% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $288.0K | +28.0% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $344.0K | +103.6% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $36.0K | +125.0% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $1.64M | -3.4% |
| Celularity Inc (CELU) | 2025-12-31 | $7.29M | -7.9% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $3.93M | -26.9% |
| Minerva Neurosciences, Inc. (NERV) | 2025-12-31 | $5.4K | 0.0% |
Compare RZLT, MIST, RFL, AVTX side by side · Screen every company in Pharmaceutical Preparations ↗